These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1493846)

  • 1. Failure of N-acetylcysteine to reduce low-density lipoprotein oxidizability in healthy subjects.
    Kleinveld HA; Demacker PN; Stalenhoef AF
    Eur J Clin Pharmacol; 1992; 43(6):639-42. PubMed ID: 1493846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of N-acetylcysteine on alcohol abstinence and alcohol-induced adverse effects in rats.
    Ferreira Seiva FR; Amauchi JF; Ribeiro Rocha KK; Souza GA; Ebaid GX; Burneiko RM; Novelli EL
    Alcohol; 2009 Mar; 43(2):127-35. PubMed ID: 19251114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.
    Stalenhoef AF; de Graaf J; Wittekoek ME; Bredie SJ; Demacker PN; Kastelein JJ
    Atherosclerosis; 2000 Nov; 153(1):129-38. PubMed ID: 11058707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis.
    Vanizor Kural B; Orem A; Cimşit G; Yandi YE; Calapoglu M
    Clin Chim Acta; 2003 Feb; 328(1-2):71-82. PubMed ID: 12559600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
    Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M
    Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylcysteine amide, a novel cell-permeating thiol, restores cellular glutathione and protects human red blood cells from oxidative stress.
    Grinberg L; Fibach E; Amer J; Atlas D
    Free Radic Biol Med; 2005 Jan; 38(1):136-45. PubMed ID: 15589382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD.
    Roob JM; Rabold T; Hayn M; Khoschsorur G; Resch U; Holzer H; Winklhofer-Roob BM
    Kidney Int Suppl; 2001 Feb; 78():S128-36. PubMed ID: 11168998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of N-acetylcysteine on sucrose-rich diet-induced hyperglycaemia, dyslipidemia and oxidative stress in rats.
    Diniz YS; Rocha KK; Souza GA; Galhardi CM; Ebaid GM; Rodrigues HG; Novelli Filho JL; Cicogna AC; Novelli EL
    Eur J Pharmacol; 2006 Aug; 543(1-3):151-7. PubMed ID: 16814277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells.
    Walters-Laporte E; Furman C; Fouquet S; Martin-Nizard F; Lestavel S; Gozzo A; Lesieur D; Fruchart JC; Duriez P; Teissier E
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):582-92. PubMed ID: 9781926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox imbalance and immune functions: opposite effects of oxidized low-density lipoproteins and N-acetylcysteine.
    Viora M; Quaranta MG; Straface E; Vari R; Masella R; Malorni W
    Immunology; 2001 Dec; 104(4):431-8. PubMed ID: 11899429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein.
    Lynch SM; Campione AL; Moore MK
    Biochim Biophys Acta; 2000 May; 1485(1):11-22. PubMed ID: 10802245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pharmacological supplementation with vitamin C on low-density lipoprotein oxidation.
    Wen Y; Cooke T; Feely J
    Br J Clin Pharmacol; 1997 Jul; 44(1):94-7. PubMed ID: 9241103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on the oxidizability and thrombogenicity of low-density lipoprotein.
    Mesa MD; Buckley R; Minihane AM; Yaqoob P
    Atherosclerosis; 2004 Aug; 175(2):333-43. PubMed ID: 15262190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress.
    Coles LD; Tuite PJ; Öz G; Mishra UR; Kartha RV; Sullivan KM; Cloyd JC; Terpstra M
    J Clin Pharmacol; 2018 Feb; 58(2):158-167. PubMed ID: 28940353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation resistance of LDL is correlated with vitamin E status in beta-thalassemia intermedia.
    Tesoriere L; D'Arpa D; Maggio A; Giaccone V; Pedone E; Livrea MA
    Atherosclerosis; 1998 Apr; 137(2):429-35. PubMed ID: 9622286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers.
    Fuller CJ; Grundy SM; Norkus EP; Jialal I
    Atherosclerosis; 1996 Jan; 119(2):139-50. PubMed ID: 8808491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidative potentiality of a Kampo formulation measured by an ex vivo study.
    Ogawa H; Xu FH; Uebaba K; Origasa H; Kondoh K; Mikage M
    J Altern Complement Med; 2009 Mar; 15(3):267-74. PubMed ID: 19292654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ACE inhibitors on oxidation of human low density lipoprotein.
    Godfrey EG; Stewart J; Dargie HJ; Reid JL; Dominiczak M; Hamilton CA; McMurray J
    Br J Clin Pharmacol; 1994 Jan; 37(1):63-6. PubMed ID: 8148219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
    Bredie SJ; de Bruin TW; Demacker PN; Kastelein JJ; Stalenhoef AF
    Am J Cardiol; 1995 Feb; 75(5):348-53. PubMed ID: 7856526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein.
    Lynch SM; Frei B
    Biochim Biophys Acta; 1997 Apr; 1345(2):215-21. PubMed ID: 9106501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.